Araştırma Makalesi
BibTex RIS Kaynak Göster

The use of gnrh agonists in the treatment of endometriomas with or without drainage

Yıl 1995, Cilt: 8 Sayı: 4, 175 - 178, 01.10.1995

Öz

In order to assess the effectiveness of GnRH-agonist (GnRH-a) therapy in the treatment of endometriomas, with or without surgical intervention, 26 women with laparoscopically proven endometriomas, greater than 3 cm diameter were recruited to the study.

Fourteen women who had 19 endometriomas (5 of them were bilaterally), had drainage of endometrioma at the initial laparoscopy. After the procedure, they had ovarian suppression with GnRH-a therapy for 6 months.

The second group which consisted of 12 women, had 17 endometriomas. No surgical procedure was performed. They received only GnRH-A therapy for 6 months. At the second -look laparoscopy, the rates of decrease in ovarian AFS scores of endometriomas and complete resolution were found as 100% and 36.8% respectively, in the first group, In the second group the response was only 17.6% (p<0.0001).

In this prospective study we found that drainage of the cyst (surgical therapy) combined with the postoperative GnRH-a suppression is a better treatment modality for endometriomas. Than the use of GnRH-a (medical therapy) alone.

Kaynakça

  • Meldrum DR, Chang RJ, Lu J, Vale W, River J, Judd ML. Medical oopherectomy using a long-acting GnRh agonist - a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982;54:81-85.
Yıl 1995, Cilt: 8 Sayı: 4, 175 - 178, 01.10.1995

Öz

Kaynakça

  • Meldrum DR, Chang RJ, Lu J, Vale W, River J, Judd ML. Medical oopherectomy using a long-acting GnRh agonist - a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982;54:81-85.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Konular Klinik Tıp Bilimleri
Bölüm Derleme
Yazarlar

A. Haberal Bu kişi benim

H. Çelikkanat Bu kişi benim

M. Uğur Bu kişi benim

G. Özakşit Bu kişi benim

N. Çiçek Bu kişi benim

P. Moröy Bu kişi benim

S. Batıoğlu Bu kişi benim

Yayımlanma Tarihi 1 Ekim 1995
Yayımlandığı Sayı Yıl 1995 Cilt: 8 Sayı: 4

Kaynak Göster

APA Haberal, A., Çelikkanat, H., Uğur, M., Özakşit, G., vd. (1995). The use of gnrh agonists in the treatment of endometriomas with or without drainage. Marmara Medical Journal, 8(4), 175-178.
AMA Haberal A, Çelikkanat H, Uğur M, Özakşit G, Çiçek N, Moröy P, Batıoğlu S. The use of gnrh agonists in the treatment of endometriomas with or without drainage. Marmara Med J. Ekim 1995;8(4):175-178.
Chicago Haberal, A., H. Çelikkanat, M. Uğur, G. Özakşit, N. Çiçek, P. Moröy, ve S. Batıoğlu. “The Use of Gnrh Agonists in the Treatment of Endometriomas With or Without Drainage”. Marmara Medical Journal 8, sy. 4 (Ekim 1995): 175-78.
EndNote Haberal A, Çelikkanat H, Uğur M, Özakşit G, Çiçek N, Moröy P, Batıoğlu S (01 Ekim 1995) The use of gnrh agonists in the treatment of endometriomas with or without drainage. Marmara Medical Journal 8 4 175–178.
IEEE A. Haberal, “The use of gnrh agonists in the treatment of endometriomas with or without drainage”, Marmara Med J, c. 8, sy. 4, ss. 175–178, 1995.
ISNAD Haberal, A. vd. “The Use of Gnrh Agonists in the Treatment of Endometriomas With or Without Drainage”. Marmara Medical Journal 8/4 (Ekim 1995), 175-178.
JAMA Haberal A, Çelikkanat H, Uğur M, Özakşit G, Çiçek N, Moröy P, Batıoğlu S. The use of gnrh agonists in the treatment of endometriomas with or without drainage. Marmara Med J. 1995;8:175–178.
MLA Haberal, A. vd. “The Use of Gnrh Agonists in the Treatment of Endometriomas With or Without Drainage”. Marmara Medical Journal, c. 8, sy. 4, 1995, ss. 175-8.
Vancouver Haberal A, Çelikkanat H, Uğur M, Özakşit G, Çiçek N, Moröy P, Batıoğlu S. The use of gnrh agonists in the treatment of endometriomas with or without drainage. Marmara Med J. 1995;8(4):175-8.